StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a research note published on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock.
Genocea Biosciences Price Performance
NASDAQ:GNCA opened at $0.00 on Thursday. Genocea Biosciences has a 1 year low of $0.00 and a 1 year high of $0.00. The stock has a market capitalization of $5,873.00, a price-to-earnings ratio of 0.00 and a beta of 1.61. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.24.
Genocea Biosciences Company Profile
Featured Stories
- Five stocks we like better than Genocea Biosciences
- Consumer Discretionary Stocks Explained
- MarketBeat Week in Review – 4/29 – 5/3
- How is Compound Interest Calculated?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 5 Top Rated Dividend Stocks to Consider
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Genocea Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genocea Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.